Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Charite University, Berlin, Germany
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of schizophrenia or related disorders(DSM-IV)
Indication for long-term treatment with antipsychotics
BMI between 20 to 30
Weight changes less than 3kg in the last 3 months before inclusion
Informed consent
You may not be if
Psychiatric comorbidity
Depot antipsychotic in the last 2 months
Antipsychotics in the last 2 weeks
Treatment with olanzapine, clozapine or ziprasidone in teh last 3 months
Treatment with drugs, that may lead to weight changes
Significant endocrine, neurological, cardiovascular, hepatic, renal, metabolic, or other medical diseases or any clinically relevant abnormalities in laboratory tests
Female subjects during pregnancy and breastfeeding
Female subjects within childbearing years who were not using adequate birth control
Patients who are judged by the investigator to be at serious suicide risk
